Flare in Neuropathy Following Rituximab Therapy for Waldenstrom’s Macroglobulinemia
- 1 January 2006
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (1), e3
- https://doi.org/10.1200/jco.2005.04.6474
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Treatment of dysimmune neuropathiesZeitschrift für Neurologie, 2005
- Initial immunoglobulin M ‘flare’ after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemiaCancer, 2004
- Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemiaAnnals of Oncology, 2004
- Proinflammatory syndrome mimicking acute rheumatoid arthritis in a patient with Waldenstrom's macroglobulinemia treated with rituximabAnnals of Hematology, 2004
- The polyneuropathy associated with Waldenström's macroglobulinaemia can be treated effectively with chemotherapy and the anti-CD20 monoclonal antibody rituximabBritish Journal of Haematology, 2000